Our efforts are endless to unlock a world of life-changing
transformative medicines by utilizing Artificial Intelligence
BioXcel LLC utilizes advanced technologies such as AI (Artificial Intelligence) to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. We are driven by scientific curiosity and passion for technology and embrace innovative approaches that help patients. We are optimizing research and development for productivity and creating novel and transformative medicines (or drugs).
Our AI-enabled platform, EvolverAI helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process.
With the combination of our in-house human expertise and technological advancement, we can change the paradigm of drug discovery.
BioXcel Therapeutics, Inc. is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI, and its approaches.
Learn More
InveniAI® LLC is a global leader in applying AI and ML tools to transform innovation across drug discovery and development by identifying and accelerating transformative therapies for diseases with unmet medical needs.
Learn More
A leading centre of research and innovation focused on developing transformative treatments. It integrates a rich and diverse cross-functional mix of highly qualified scientific, medical, commercial, IP, and Artificial Intelligence.
Learn MoreAt every step of our journey, we make the most of our in-house scientific expertise. We believe with advanced technologies and well-researched endeavours, together we can create novel discoveries. BioXcel is deeply involved in creating breakthroughs in the following categories of diseases:
Excellence starts at the top. Meet our leaders who inspire us at every step of our journey
CEO & Chairman
COO, BioXcel LLC., USA
Managing Director, BioXcel India
VP, Corporate Strategy & Innovation, BioXcel India
CEO & Chairman
COO, BioXcel LLC., USA
Managing Director, BioXcel, India
Chairman, Scientific Advisory Board
There is nothing more important than making people live healthier and longer lives. Check how BioXcel’s AI platform is extending the gift of science to people.
With the right combination of human expertise, technology, and science, we can bring positive outcomes in patients’ lives by:
A live and dynamic cloud-based pharma analytics platform revolutionizing decision making by providing live intelligence on treatment paradigms, product opportunities, key market movers, product blueprints, portfolio impact and commercial launch scenarios.
The suite's cognitive insights help identify potential market winners and streamline internal and external innovation, enabling better R&D prioritization and justifying sound investment decisions. Powered by an intuitive and interactive user interface that enables first mover advantage, predictive simulation, risk mitigation and operational excellence.
BioXcel Featured in Fierce Biotech The recent uptick in interest in drug repurposing, the popularity of which ebbs and flows, could give the team a tailwind..
READ MORE
First and only FDA-approved orally dissolving sublingual film for mild, moderate or severe agitation in patients with schizophrenia...
READ MORE
- Collaboration enables Kyowa Kirin's R&D team to access InveniAI's data-driven discovery platform in expanded therapeutic areas...
READ MORE
Collaboration to create transformative therapeutics for immune diseases by combining InveniAI's validated AI-based platform, AlphaMeld®,...
READ MORE
Much Needed Non-Opioid, Non-Addictive Pain Treatments are the Focus for Pain Therapeutics Development Efforts...
READ MORE
BioXcel said today it has joined with Takeda Pharmaceutical’s U.S.-based global development group to repurpose...
READ MORE
Email at
careers@bioxcel.com
+1 475 237 9007
Email at
info@bioxcel.com
+1 475 237 9007
